FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions
[PMID: 12897445] Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL
Some conditions are: Pregnancy Nursing Active cancers Certain medications Brain disorders *Some medicines can decrease the effectiveness of peptides You do not want to use Semorelin-Ipamorelin-CJC1295 therapy if your body is making enough growth hormone and you feel great
It is a reason to approach it with a clinician who understands the literature and who can situate it within your specific metabolic and hormonal profile
The combo lightens dark spots and post-inflammatory hyperpigmentation, inhibits melanin production, neutralizes free radicals that cause cell damage, strengthen the skin barrier and boost collagen synthesis
Appearance: blue, odorless liquid